AU779347B2 - Iminocyclitol inhibitors of hexoaminidase and glycosidase - Google Patents

Iminocyclitol inhibitors of hexoaminidase and glycosidase Download PDF

Info

Publication number
AU779347B2
AU779347B2 AU48444/00A AU4844400A AU779347B2 AU 779347 B2 AU779347 B2 AU 779347B2 AU 48444/00 A AU48444/00 A AU 48444/00A AU 4844400 A AU4844400 A AU 4844400A AU 779347 B2 AU779347 B2 AU 779347B2
Authority
AU
Australia
Prior art keywords
mixture
methyl
solution
added
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU48444/00A
Other languages
English (en)
Other versions
AU4844400A (en
Inventor
Jungie Liu
Chi-Huey Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU4844400A publication Critical patent/AU4844400A/en
Application granted granted Critical
Publication of AU779347B2 publication Critical patent/AU779347B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU48444/00A 1999-05-11 2000-05-11 Iminocyclitol inhibitors of hexoaminidase and glycosidase Ceased AU779347B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13354999P 1999-05-11 1999-05-11
US60/133549 1999-05-11
PCT/US2000/013048 WO2000068194A1 (en) 1999-05-11 2000-05-11 Iminocyclitol inhibitors of hexoaminidase and glycosidase

Publications (2)

Publication Number Publication Date
AU4844400A AU4844400A (en) 2000-11-21
AU779347B2 true AU779347B2 (en) 2005-01-20

Family

ID=22459157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48444/00A Ceased AU779347B2 (en) 1999-05-11 2000-05-11 Iminocyclitol inhibitors of hexoaminidase and glycosidase

Country Status (7)

Country Link
EP (1) EP1181274B1 (enExample)
JP (1) JP2002544191A (enExample)
AT (1) ATE487697T1 (enExample)
AU (1) AU779347B2 (enExample)
CA (1) CA2373183C (enExample)
DE (1) DE60045217D1 (enExample)
WO (1) WO2000068194A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003008379A1 (en) * 2001-06-08 2003-01-30 Mitsubishi Chemical Corporation Azasugar compounds
JP2007518814A (ja) * 2004-01-20 2007-07-12 ザ・スクリップス・リサーチ・インスティテュート グリコシダーゼ阻害剤によるほ乳類での変性軟骨症の治療
EP2057171A4 (en) 2006-08-31 2010-04-21 Univ Fraser Simon SELECTIVE GLYCOSIDASE INHIBITORS AND APPLICATIONS THEREOF
BR112013016179A2 (pt) 2010-12-23 2018-07-10 Alectos Therapeutics Inc inibidores seletivos da glicosidase e usos dos mesmos.
US9718854B2 (en) 2011-03-31 2017-08-01 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
WO2013000086A1 (en) 2011-06-27 2013-01-03 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
EP2890675A4 (en) * 2012-08-31 2016-01-13 Alectos Therapeutics Inc GLYCOSIDASE INHIBITORS AND USES THEREOF
EP2890676B1 (en) 2012-08-31 2018-12-05 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
EP2914604A4 (en) 2012-10-31 2016-07-20 Alectos Therapeutics Inc GLYCOSIDASE INHIBITORS AND USES THEREOF
CA2939380A1 (en) * 2014-02-12 2015-08-20 Amicus Therapeutics, Inc. Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of mps iiic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250703A (en) * 1992-09-29 1993-10-05 Monsanto Company Pyrrolidin-3,4-diol derivatives of heptitols and preparation thereof
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Y. TAKAOKA J. ORG. CHEM. 1993, VOL 58, P4809-4812 *

Also Published As

Publication number Publication date
CA2373183A1 (en) 2000-11-16
DE60045217D1 (de) 2010-12-23
CA2373183C (en) 2009-12-08
EP1181274B1 (en) 2010-11-10
JP2002544191A (ja) 2002-12-24
AU4844400A (en) 2000-11-21
EP1181274A4 (en) 2005-08-17
WO2000068194A1 (en) 2000-11-16
ATE487697T1 (de) 2010-11-15
EP1181274A1 (en) 2002-02-27

Similar Documents

Publication Publication Date Title
AU724003B2 (en) 2-alkylpyrrolidines
Kajimoto et al. Enzyme-catalyzed aldol condensation for asymmetric synthesis of azasugars: synthesis, evaluation, and modeling of glycosidase inhibitors
EP0268190B1 (en) Prolinal derivatives
US5863903A (en) Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes
US6774140B1 (en) Iminocyclitol inhibitors of hexoaminidase and glycosidase
Cardona et al. Straightforward Synthesis of (1→ 2)-Linked Pseudo Aza-C-disaccharides by the Novel Cycloaddition of Enantiopure Cyclic Nitrones to Glycals
Ernholt et al. Enantiospecific Synthesis of 1‐Azafagomine
CZ63199A3 (cs) Sloučeniny typu substituovaných cyklických aminů jako inhibitory metaloproteáz, způsob jejich přípravy a použití jako léčiv
JPS6058751B2 (ja) プロリン関連化合物ならびにその製法
EA007434B1 (ru) Ингибиторы dpiv на основе глутаминила
EP1181274B1 (en) Iminocyclitol inhibitors of hexoaminidase and glycosidase
Pandey et al. A new access to polyhydroxy piperidines of the azasugar class: synthesis and glycosidase inhibition studies
WO1995024391A1 (en) Piperidines and pyrrolidines
Matassini et al. Polyhydroxyamino‐Piperidine‐Type Iminosugars and Pipecolic Acid Analogues from ad‐Mannose‐Derived Aldehyde
Lundt Aldonolactones as chiral synthons: Preparation of highly functionalized, optically active pyrrolidines, piperidines, carbocycles and tetrahydrofurans
Lillelund et al. Isofagomine lactams, synthesis and enzyme inhibition
Dondoni et al. Cross-Metathesis of C-Allyl Iminosugars with Alkenyl Oxazolidines as a Key Step in the Synthesis of C-Iminoglycosyl α-Amino Acids. 1 A Route to Iminosugar Containing C-Glycopeptides
US6066667A (en) Substituted furanones, compositions and antiarthritic use
US20100113549A1 (en) Pyrrolidine compounds
AU2002361982B2 (en) D-Proline Prodrugs
CN110128315B (zh) 化合物及其制备方法与应用、糖苷酶抑制剂
Koulocheri et al. Stereoselective Michael addition of thiophenols, amino acids and hydrazoic acid to (2S)-hydroxymethyl-dihydropyridone as a convenient route to novel azasugar derivatives
EP1657244A1 (en) 2-thiaquinolizidines as glycosidase and glycosyltransferase inhibitors
Slavinska et al. Asymmetric reductive alkylation of alanylproline by the ethyl esters of 4-substituted 2-oxobutenoic acids
ES2004443A6 (es) Procedimiento de preparacion del acido 1-(3-bromo-(2s)-metilpropionil)-pirrolidin-(2s)-carboxilico